A new company has entered the public psychedelic markets, with an alternative drug-to-market approach. Using Real World Evidence trials, Albert Labs is expecting to legally provide psilocybin to patients in the UK much earlier than companies working with to get FDA approval.
A former Moderna executive has taken a leadership position in MAPS, the largest nonprofit in the psychedelics space.
In Oklahoma, a psilocybin decriminalization bill is headed to the state senate after getting approval from the state's lower chamber.
Albert Labs, Psychedelic Biotech Company Shares Now Available On Canadian Exchange
Albert Labs, a British-Columbia-based biotech company, announced Thursday that it closed its private placement and that its shares will begin trading on the Canadian Securities Exchange (CSE). Albert Labs will trade under the ticker symbol “ABRT.” Read the full story…
Former Moderna Vice President Joins Psychedelics Company In Phase 3 Trials For Ecstasy
Michael Mullette, a former Moderna MNRA vice president is taking a senior leadership position in the MAPS Public Benefit Corporation, a biotech company in the psychedelics sector. Read the full story…
GOP-Led Psilocybin Decriminalization & Research Bill Heads To Oklahoma Senate
A bill to decriminalize low-level possession of psilocybin and promote research into the therapeutic potential of the psychedelic is heading to the Oklahoma Senate after House members gave it the green light. Read the full story…
Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory Council
The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the psychedelics space, composed of key thought leaders sharing insights into industry developments, sector trends and breaking news. Read the full release…
What Are Entheogens And How They Remove Us From Our Day-To-Day Experience: Entheogenic Culture And History
Entheogens remove us from our day-to-day experience of life and, in some cases, remove us from time and space, imparting a sense of the infinite. Read the full story…
The Road To Psychedelics Legalization
In the midst of a psychedelic renaissance, it’s crucial to recognize that the use of psychedelics is not a new phenomenon. But what has changed in recent years is a concerted effort to increase our scientific understanding of their applications in natural medicine and therapeutic healing—and everyone who’s interested can play a part. Read the full story…
Novamind To Conduct Phase II Psilocybin Trial For Major Depressive Disorder
Novamind Inc. NVMDF NM will conduct a phase II clinical trial investigating psilocybin for major depressive disorder sponsored by the Usona Institute. The company completed its first patient randomization at its Draper, Utah research site. Read the full story…
The company also granted an aggregate of 325,000 restricted share units effective March 11, 2022, to certain executives and employees of the company. Read the full story...
Psychedelic Fashion: Harry Styles And Fleetwood Mac Launch 'Shroom Bloom'
Harry Styles, the popular British singer-songwriter who rose to fame with the boy band One Direction, has launched a mind-blowing line of psychedelic clothing under the brand, Pleasing. Read the full story…
Washington State Voters To Weigh In On 'Facilitated' Psilocybin Sessions: Advocates File Legalization Initiative
Washington State lawmakers kicked off 2022 with the introduction of a bill that would create a state-licensed program to provide medical treatment with psilocybin, the main active component of psychedelic mushrooms. Read the full story…
NeonMind Completes Pre-IND Consultation With FDA And Strengthens Medical Services Division
NeonMind Biosciences Inc. NMDBF provided a summary of business highlights on the company's activities and progress across its pharmaceutical and medical services divisions. Read the full story…
PSYC Launches Spotlight Media Subsidiary As It Prepares For Future Media Expansion
PSYC Corporation PSYC a psychedelics news and information platform, has announced that the company incorporated Spotlight Media Corporation, its wholly-owned subsidiary. Read the full story…
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!